- Investing Ideas
- /
- Belgian Pharmaceuticals & Biotech Top Stock Picks from Analysts
Belgian Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
3
0 new
Companies which are more than 50% undervalued based on analyst price target.
3 companies
UCB
Market Cap: €25.9b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€136.30
7D
1.2%
1Y
13.6%
Financière de Tubize
Market Cap: €4.9b
Operates as a mono holding company whose sole investment is a stake in UCB which is a biopharma company in Belgium.
TUB
€110.20
7D
1.8%
1Y
20.0%
Hyloris Pharmaceuticals
Market Cap: €187.6m
Engages in the research, development, and manufacture of pharmaceutical products to address unmet medical needs.
HYL
€6.70
7D
16.5%
1Y
-44.2%